We are live on ! Find out more
CFO

Callan Family Office Portfolio holdings

AUM $4.41B
1-Year Est. Return 26.21%
This Fund
S&P 500
This Quarter Est. Return
-1.19%
1 Year Est. Return
+26.21%
3 Year Est. Return
+68.96%
5 Year Est. Return
10 Year Est. Return
AUM
$1.33B
AUM Growth
-$239M
Cap. Flow
-$202M
Cap. Flow %
-15.12%
Top 10 Hldgs %
30.52%
Holding
657
New
30
Increased
136
Reduced
341
Closed
114

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$20M
2
AAPL icon
Apple
AAPL
+$19.1M
3
NVDA icon
NVIDIA
NVDA
+$18.1M
4
AMZN icon
Amazon
AMZN
+$14.7M
5
COST icon
Costco
COST
+$8.84M

Sector Composition

Rank Sector Weight
1 Technology 17.08%
2 Financials 12.66%
3 Healthcare 9.69%
4 Communication Services 6.06%
5 Consumer Discretionary 5.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLE icon
151
State Street Energy Select Sector SPDR ETF
XLE
$37.6B
$1.63M 0.12%
34,874
+9,290
+36% +$419K
BA icon
152
Boeing
BA
$185B
$1.61M 0.12%
9,454
+4,457
+89% +$771K
XLK icon
153
State Street Technology Select Sector SPDR ETF
XLK
$123B
$1.59M 0.12%
+15,442
New +$1.75M
PEP icon
154
PepsiCo
PEP
$190B
$1.58M 0.12%
10,529
-2,093
-17% -$312K
CARR icon
155
Carrier Global
CARR
$52.8B
$1.56M 0.12%
24,532
-5,040
-17% -$335K
CIBR icon
156
First Trust NASDAQ Cybersecurity ETF
CIBR
$15.3B
$1.54M 0.12%
24,500
SYK icon
157
Stryker
SYK
$130B
$1.54M 0.12%
4,137
-269
-6% -$102K
AMP icon
158
Ameriprise Financial
AMP
$48.8B
$1.54M 0.12%
3,175
-739
-19% -$388K
PGR icon
159
Progressive
PGR
$125B
$1.52M 0.11%
5,370
-6,977
-57% -$1.82M
CAT icon
160
Caterpillar
CAT
$387B
$1.51M 0.11%
4,570
-8,187
-64% -$2.92M
RMD icon
161
ResMed
RMD
$30.7B
$1.5M 0.11%
6,717
-61
-0.9% -$14.2K
IFF icon
162
International Flavors & Fragrances
IFF
$21.9B
$1.49M 0.11%
19,223
+6,820
+55% +$563K
MS icon
163
Morgan Stanley
MS
$340B
$1.49M 0.11%
12,772
-12,648
-50% -$1.63M
ADP icon
164
Automatic Data Processing
ADP
$108B
$1.45M 0.11%
4,743
-13,065
-73% -$3.94M
NEE icon
165
NextEra Energy
NEE
$177B
$1.43M 0.11%
20,181
-13,018
-39% -$919K
AZN icon
166
AstraZeneca
AZN
$250B
$1.41M 0.11%
9,625
-1,860
-16% -$269K
TEL icon
167
TE Connectivity
TEL
$62.6B
$1.41M 0.11%
9,991
-28
-0.3% -$4.14K
BMRN icon
168
BioMarin Pharmaceuticals
BMRN
$12.4B
$1.4M 0.1%
19,774
+12,304
+165% +$828K
GEHC icon
169
GE HealthCare
GEHC
$32.4B
$1.38M 0.1%
17,055
-138
-0.8% -$11.9K
SPOT icon
170
Spotify
SPOT
$100B
$1.36M 0.1%
2,465
+1,085
+79% +$606K
ZBRA icon
171
Zebra Technologies
ZBRA
$17.8B
$1.35M 0.1%
4,792
+24
+0.5% +$8.2K
MUSA icon
172
Murphy USA
MUSA
$9.61B
$1.34M 0.1%
2,851
-2,203
-44% -$1.05M
CDNS icon
173
Cadence Design Systems
CDNS
$93.4B
$1.34M 0.1%
5,266
+2,243
+74% +$624K
BR icon
174
Broadridge
BR
$19B
$1.33M 0.1%
5,503
-3
-0.1% -$706
ICE icon
175
Intercontinental Exchange
ICE
$84.4B
$1.32M 0.1%
7,662
-2,436
-24% -$399K

Similar funds

Callan Family Office's Q1 2025 Portfolio in Review

As of Q1 2025, Callan Family Office held 657 positions worth $1.33B, down 15% from $1.57B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Callan Family Office withdrew a net $202M in Q1 2025, closing 114 positions and reducing 341 holdings. Its most notable exit was iShares MSCI ACWI ex US ETF, an estimated $3.63M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Callan Family Office opened a new position in Berkshire Hathaway Class A worth $4.79M.

  • Callan Family Office's largest Q1 2025 buy was Berkshire Hathaway Class A: 6 shares worth $4.79M.
  • Callan Family Office added most to iShares Core S&P 500 ETF in Q1 2025, an estimated $5.25M increase.
  • Callan Family Office's biggest Q1 2025 reduction was Microsoft, cutting an estimated $20M.
  • Callan Family Office fully exited iShares MSCI ACWI ex US ETF in Q1 2025, selling an estimated $3.63M.
  • Callan Family Office's ten largest holdings make up 31% of its $1.33B portfolio in Q1 2025.
  • Callan Family Office opened 30 new positions and closed 114 in Q1 2025.
  • Callan Family Office's portfolio value fell 15% quarter-over-quarter to $1.33B.

Based on Callan Family Office's 13F filing for Q1 2025, filed 13 May 2025.